Effect of administrated activity, admission number and TSH level on radiation retention curve of patients taking iodine-131 therapy for differentiated thyroid carcinoma: Looking beyond established regulations

Authors

  • Ali Mahmoud-Pashazadeh The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
  • Majid Assadi The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
  • Masoud Moslehi Department of Nuclear Medicine, Seyedoshohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  • Rahim Tahmasebi Department of Biostatistics, School of Public Health, Bushehr University of Medical Sciences, Bushehr, Iran|Department of Health Promotion, The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran
Abstract:

Introduction: Retention of I-131 in the body of patients with differentiated thyroid carcinoma (DTC) has a direct effect on therapeutic outcome of radioiodine therapy. There are several factors that may influence retention time of radioiodine in the body of these patients. In this study we are going to assess effects of administered radioiodine activity, serum thyroid stimulating hormone (TSH) level and also admission/administration number on the retention of I-131 in the body of DTC patients. Methods: Number of 92 DTC patients, with different TSH levels ranged from 32 mIU/ml to 250 mIU/ml, was treated with different I-131 activities ranged from 1850 MBq to 7400 MBq. They received one, two or three sessions of radioiodine therapy based on severity of cancer. Post-therapy dosimetry for all the patients was performed immediately, 6 hours, 12 hours, 24 hours and one week after the administration of  activity to calculate clearance rate of the I-131. Results:Basedon our observations,there wasa direct correlation between administered radioiodine activities to the patients and clearance rate of the activity from their bodies. Also, those patients who had been admitted for the third time to receive their third radioiodine administration had higher clearance rate as compared to those who had their first or second admissions. TSH level above 32 mIU/ml did not show any effect on clearance rate of I-131. Conclusion: Based on our findings, clearance rate of I-131 is affected by amount of administered radioiodine activities to the patients and number of radioiodine therapy sessions, but serum TSH level above 32 mIU/ml had no effect on this quantity.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Determination of radiation dose rates and urinary activity of patients received Sodium Iodide-131 for treatment of differentiated thyroid carcinoma [Persian]

Sodium Iodide-131 is administrated for treatment of hyperthyroidism and thyroid cancer. Iodine-131 has multiple routs of excretion (Urine, saliva, sweat, milk, feces, exhalation) from the body. Patients receiving Sodium Iodide-131 therapy exposes other persons and the environment to unwanted radiation and contamination. The major source of radiation dose from administration of Iodine-131 ...

full text

Comparison and evaluation of value of thymoglobulin level in serum and I-131 whole body scan (I-131 WBS) in patients with differentiated thyroid carcinoma [Persian]

  This study was done in research institute of nuclear medicine from 1988-1992 for evaluation of the value of serum thyroglobulin level in comparison with 1-131 whole body scan (1-131 WBS) in patients with differentiated thyroid carcinoma. 204 patients who had total or near total thyroidectomy treated with 1-131 were evaluated in this study. Out of 204 patients 136 di...

full text

Iodine 131 treatment for differentiated thyroid carcinoma in patients with end stage renal failure: dosimetric, radiation safety, and practical considerations.

BACKGROUND Iodine 131 ablation following total thyroidectomy is considered an indispensable element of successful treatment of differentiated thyroid carcinoma (Dtc). because of the essential role of the kidneys in iodine clearance, (131)I therapy of Dtc in patients with end stage renal disease, particularly those maintained on haemodialysis, present a number of special features: the (131)I act...

full text

Evaluation of response to I-131 ablative therapy in patients with differentiated thyroid carcinoma: A five year retrospective study [Persian]

Differentiated thyroid carcinomas usually show good uptake and response to I-131 ablative treatment. In this study, 90 patients following near total thyroidectomy who were referred to our institute for I-131 therapy are retrospectively studied. The patients are divided in two groups. Group 1 revealed complete ablation after one dose of I-131. Group 2 needed more than one dose of I-131 for...

full text

Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.

OBJECTIVE In the current study, we examined whether selenium supplementation during iodine-131 (131I) treatment had a radio-protective effect on salivary glands. SUBJECTS AND METHODS Sixteen patients with differentiated thyroid cancer were prospectively enrolled in the study. Patients after total thyroidectomy, before 131I treatment, were divided into two groups; 8 patients in the selenium gr...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 26  issue 1

pages  47- 53

publication date 2018-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023